Michael M. Wick
2009
In 2009, Michael M. Wick earned a total compensation of $1M as President, Chief Executive Officer and Chairman at MabVax Therapeutics Holdings, a 14% decrease compared to previous year.
Compensation breakdown
| Option Awards | $490,078 |
|---|---|
| Salary | $514,000 |
| Total | $1,004,078 |
Wick received $514K in salary, accounting for 51% of the total pay in 2009.
Wick also received $490.1K in option awards.
Rankings
In 2009, Michael M. Wick's compensation ranked 4,451st out of 9,885 executives tracked by ExecPay. In other words, Wick earned more than 55.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,451 out of 9,885 | 55th |
Division Manufacturing | 1,586 out of 3,690 | 57th |
Major group Chemicals And Allied Products | 310 out of 866 | 64th |
Industry group Drugs | 187 out of 638 | 71st |
Industry Pharmaceutical Preparations | 148 out of 446 | 67th |
Source: SEC filing on April 7, 2010.
Wick's colleagues
We found four more compensation records of executives who worked with Michael M. Wick at MabVax Therapeutics Holdings in 2009.
2009
Cynthia Butitta
MabVax Therapeutics Holdings
Chief Financial Officer
2009
Marc Steuer
MabVax Therapeutics Holdings
Senior Vice President, Business Development
2009
William Kaplan
MabVax Therapeutics Holdings
General Counsel
2009
Stefan Ryser
MabVax Therapeutics Holdings